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Introduction
Percutaneous cardiac interventions are currently per-
formed under X-ray guidance. MR-guided cardiac inter-
ventions have been previously described but mainly in
animals. Their translation into humans has been limited
by the lack of MR-compatible and safe equipment, such
as MR guidewires with mechanical characteristics simi-
lar to standard guidewires.
Purpose
We are presenting the initial results of the first-in-man
clinical trial on MR-guided interventions in patients
with congenital heart disease.
Methods
Ethics and UK regulatory authority approval were
obtained prior to commencement of the trial. Inclusion
criteria included patients above 2 years of age with great
arterial valve stenosis, branch pulmonary artery or aortic
arch stenosis and patients that needed balloon dilation
of existing stents.
Results
Seven patients aged 3 - 64 years have been recruited so
far. Five patients have undergone successful interven-
tions for pulmonary valve stenosis (n=4) and native aor-
tic coarctation (n=1). One patient with left pulmonary
artery stent underwent right heart catheterisation with
the aid of the new MR-wire, but the gradient across the
stent was only 5mmHg, hence no intervention was
required. The last patient (8 year old child) with severe
aortic stenosis had an unsuccessful attempt at balloon-
ing the aortic valve, due to the inability of turning the
wedge catheter into the ascending aorta, as the balloon
of the catheter kept being pushed back by the aortic ste-
nosis jet. Catheter manipulations were monitored with
real time MRI sequence with interactive modification of
imaging plane and slice position. Temporal resolution
was 11-12 frames/sec. Median procedure and catheteri-
sation times were 180 and 110 min, respectively. All
patients were discharged home the day after the proce-
dure with > 50% reduction of the stenosis gradient and
no procedural complications.
Conclusions
Initial results of the first-in-man clinical trial on
MR-guided cardiac interventions are encouraging that
with the availability of the new MR compatible and safe
guidewire, certain percutaneous cardiac interventions
will become feasible to perform solely under MR-
guidance in the future.
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